Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
9.98
0.00 (0.00%)
Jun 6, 2025, 3:02 PM - Market open
Embecta Revenue
Embecta had revenue of $259.00M in the quarter ending March 31, 2025, a decrease of -9.82%. This brings the company's revenue in the last twelve months to $1.08B, down -4.68% year-over-year. In the fiscal year ending September 30, 2024, Embecta had annual revenue of $1.12B with 0.21% growth.
Revenue (ttm)
$1.08B
Revenue Growth
-4.68%
P/S Ratio
0.54
Revenue / Employee
$514,048
Employees
2,100
Market Cap
583.26M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
EMBC News
- 9 days ago - embecta to Participate in Investor Events - GlobeNewsWire
- 15 days ago - embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day - GlobeNewsWire
- 21 days ago - Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply - Seeking Alpha
- 4 weeks ago - Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 5 weeks ago - Embecta to host Analyst and Investor Day on May 22, 2025 - GlobeNewsWire
- 6 weeks ago - embecta to Report Fiscal Second Quarter 2025 Financial Results - GlobeNewsWire